NewsRoom Articles - Page 852 of 1390

TuesdayMar 19, 2019 2:00 pm

RiceBran Technologies (NASDAQ: RIBT) Attends 31st Annual ROTH Conference

RiceBran Technologies (NASDAQ: RIBT) is a specialty ingredient company servicing the food, animal nutrition, and specialty ingredient products markets. The company utilizes proprietary and patented intellectual property to convert rice bran, one of the world’s most underutilized food sources, into a number of highly nutritious and clean label ingredient products. The global target markets for company products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers. For more information, visit the company's website at www.ricebrantech.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that…

TuesdayMar 19, 2019 2:00 pm

RF Industries Ltd. (NASDAQ: RFIL) Attends 31st Annual ROTH Conference

RF Industries (NASDAQ: RFIL) designs and manufactures a broad range of interconnect products across diversified, growing markets including wireless/wireline telecom, data communications and industrial. The company's products include RF connectors, coaxial cables, wire harnesses, fiber optic cables and custom cabling. RF Industries is headquartered in San Diego, California with operations in New York and Connecticut. For more information, visit the company's website at www.rfindustries.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner…

TuesdayMar 19, 2019 2:00 pm

Resverlogix Corp. (OTC: RVXCF) (TSX: RVX) Attends 31st Annual ROTH Conference

Resverlogix (OTC: RVXCF) (TSX: RVX) is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with high-risk cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease treated with hemodialysis, neurodegenerative disease, Fabry disease, peripheral artery disease and other orphan diseases, while maintaining a well described…

TuesdayMar 19, 2019 2:00 pm

Restoration Robotics Inc. (NASDAQ: HAIR) Attends 31st Annual ROTH Conference

Restoration Robotics (NASDAQ: HAIR) is a medical device company developing and commercializing the ARTAS and ARTAS iX Robotic Hair Restoration System. The ARTAS Systems are the first and only physician-assisted systems to dissect and assist in the harvesting of follicular units directly from the scalp, create recipient implant sites using proprietary algorithms and simultaneously implant the hair follicles into the designated sites. The company has unique expertise in machine vision, image guidance, visual serving and robotics, as well as developing intuitive interfaces to manage these technologies. For more information, visit the company's website at www.artas.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

TuesdayMar 19, 2019 1:30 pm

Resideo Technologies Inc. (NYSE: REZI) Attends 31st Annual ROTH Conference

Resideo Technologies (NYSE: REZI) is a global provider of critical comfort and security solutions primarily in residential environments, and distributor of low-voltage and security products. Resideo has a presence in more than 150 million homes, with 15 million systems installed in homes each year. The company has a 40-year, exclusive license to use the Honeywell Home brand for products and will continue to serve more than 100,000 contractors through its ADI Global Distribution business, which exports to more than 100 countries from more than 200 stocking locations around the world. For more information, visit the company's website at www.resideo.com. About…

TuesdayMar 19, 2019 1:30 pm

Research Solutions Inc. (RSSS) Attends 31st Annual ROTH Conference

Research Solutions (OTCQB: RSSS) provides workflow efficiency solutions for R&D-driven organizations in life sciences, technology and academia worldwide. The company’s Software-as-a-Service platform provides tools or "Gadgets" that allow users to discover, access, manage and collaborate around science, technology and medical (STM) content and data. The company’s customers range from 70 percent of the top 25 global pharmaceutical companies to emerging small and medium-sized businesses. Research Solutions generates recurring revenue from subscriptions to its SaaS platform and transactional revenue from the sale of STM content. For more information, visit the company's website at www.researchsolutions.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

TuesdayMar 19, 2019 1:30 pm

Research Frontiers Inc. (NASDAQ: REFR) Attends 31st Annual ROTH Conference

Research Frontiers (NASDAQ: REFR) is a technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to over 40 companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, visit the company's website at www.SmartGlass.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

TuesdayMar 19, 2019 1:30 pm

CynergisTek Inc. (NYSE American: CTEK) Attends 31st Annual ROTH Conference

CynergisTek (NYSE American: CTEK) is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve security, privacy, compliance, and document output goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity as well as the 2017 Best in KLAS winner for Cybersecurity Advisory…

TuesdayMar 19, 2019 1:30 pm

Renewable Energy Group Inc. (NASDAQ: REGI) Attends 31st Annual ROTH Conference

Renewable Energy Group (NASDAQ: REGI) is a provider of cleaner, lower carbon intensity products and services. The company is an international producer of biomass-based diesel, a developer of renewable chemicals and North America's largest producer of advanced biofuel. REG utilizes an integrated procurement, distribution, and logistics network to convert natural fats, oils, greases, and sugars into lower carbon intensity products. With 14 active biorefineries, a feedstock processing facility, research and development capabilities and a diverse and growing intellectual property portfolio, REG is committed to being a long-term leader in bio-based fuel and chemicals. For more information, visit the company's website…

TuesdayMar 19, 2019 1:30 pm

CymaBay Therapeutics Inc. (NASDAQ: CBAY) Attends 31st Annual ROTH Conference

CymaBay Therapeutics (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with nonalcoholic steatohepatitis (NASH). Two phase 2 studies of seladelpar established proof-of-concept in PBC. CymaBay is currently conducting a phase 3 study of seladelpar for PBC and a phase 2b study of seladelpar for NASH. For more information, visit the company's website at www.cymabay.com. About NetworkNewsWire NetworkNewsWire (NNW) is…